Ed Arce
Stock Analyst at Westpark Capital
(4.85)
# 392
Out of 4,983 analysts
1033
Total ratings
48.8%
Success rate
22.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ed Arce
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics | Initiated Coverage: Buy | $7.5 → $4.5 | $0.8955 | +402.51% | 86 | Sep 8, 2026 | |
| TLPH Talphera | Initiated Coverage: Buy | $6 → $3 | $1.17 | +156.41% | 88 | Apr 30, 2026 | |
| MTVA MetaVia | Reiterated: Buy | $132 | $1.59 | n/a | 9 | Sep 17, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $60 | $16.93 | n/a | 72 | Apr 11, 2025 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $75 | $4.77 | n/a | 33 | Apr 11, 2025 | |
| IVA Inventiva | Reiterated: Buy | $13 | $3.75 | n/a | 32 | Apr 3, 2025 | |
| GALT Galectin Therapeutics | Reiterated: Hold | n/a | $3.71 | n/a | 56 | Apr 2, 2025 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $70 | $5.17 | n/a | 6 | Mar 31, 2025 | |
| ASMB Assembly Biosciences | Reiterated: Hold | n/a | $25.34 | n/a | 30 | Mar 21, 2025 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $240 | $1.39 | n/a | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.13 | n/a | 36 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $11.17 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $405 | $534.40 | n/a | 42 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $72 | $98.82 | n/a | 60 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 | $3.38 | n/a | 13 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $14.50 | n/a | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $12.52 | n/a | 16 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $5.07 | n/a | 37 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $21.93 | n/a | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $22 | $64.74 | n/a | 26 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 44 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $16.96 | n/a | 90 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.16 | n/a | 12 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $0.099 | n/a | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $34.27 | n/a | 12 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 51 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.72 | n/a | 13 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.47756 | n/a | 33 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.54 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €3.41 | n/a | 15 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $31 | $22.38 | n/a | 11 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.2591 | n/a | 5 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.12 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.25 | $0.0112 | n/a | 14 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $29.36 | n/a | 2 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4999 | n/a | 8 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 1 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.70 | n/a | 12 | Jan 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $5 | $0.0001 | n/a | 8 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.5 | $0.0016 | n/a | 2 | Mar 19, 2013 |
Akebia Therapeutics
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $7.5 → $4.5
Current: $0.8955
Upside: +402.51%
Talphera
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $6 → $3
Current: $1.17
Upside: +156.41%
MetaVia
Sep 17, 2025
Reiterated: Buy
Price Target: $132
Current: $1.59
Upside: n/a
Arcturus Therapeutics Holdings
Apr 11, 2025
Reiterated: Buy
Price Target: $60
Current: $16.93
Upside: n/a
Unicycive Therapeutics
Apr 11, 2025
Reiterated: Buy
Price Target: $75
Current: $4.77
Upside: n/a
Inventiva
Apr 3, 2025
Reiterated: Buy
Price Target: $13
Current: $3.75
Upside: n/a
Galectin Therapeutics
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.71
Upside: n/a
Aligos Therapeutics
Mar 31, 2025
Reiterated: Buy
Price Target: $70
Current: $5.17
Upside: n/a
Assembly Biosciences
Mar 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $25.34
Upside: n/a
Acurx Pharmaceuticals
Mar 20, 2025
Reiterated: Buy
Price Target: $240
Current: $1.39
Upside: n/a
Mar 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Mar 11, 2025
Reiterated: Buy
Price Target: $32
Current: $11.17
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $400 → $405
Current: $534.40
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $66 → $72
Current: $98.82
Upside: n/a
Feb 20, 2025
Reiterated: Hold
Price Target: $5.5
Current: $3.38
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: $95
Current: $14.50
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $18
Current: $12.52
Upside: n/a
Jan 21, 2025
Reiterated: Buy
Price Target: $5
Current: $5.07
Upside: n/a
Jan 14, 2025
Reiterated: Buy
Price Target: $48
Current: $21.93
Upside: n/a
Jan 14, 2025
Reiterated: Buy
Price Target: $18 → $22
Current: $64.74
Upside: n/a
Sep 10, 2024
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Sep 5, 2024
Reiterated: Buy
Price Target: $13
Current: $16.96
Upside: n/a
Apr 24, 2024
Rated: Hold
Price Target: n/a
Current: $1.16
Upside: n/a
Mar 26, 2024
Reiterated: Buy
Price Target: $120
Current: $0.099
Upside: n/a
Jan 25, 2024
Reiterated: Buy
Price Target: $25
Current: $34.27
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 21, 2021
Reiterated: Hold
Price Target: n/a
Current: $17.72
Upside: n/a
Nov 29, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.47756
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $11.54
Upside: n/a
Mar 18, 2020
Reiterated: Buy
Price Target: €12.00
Current: €3.41
Upside: n/a
Feb 7, 2020
Reiterated: Buy
Price Target: $29 → $31
Current: $22.38
Upside: n/a
Nov 11, 2019
Reiterated: Hold
Price Target: n/a
Current: $0.2591
Upside: n/a
Aug 12, 2019
Reiterated: Buy
Price Target: $27
Current: $1.12
Upside: n/a
Mar 14, 2019
Reiterated: Hold
Price Target: $1.25
Current: $0.0112
Upside: n/a
Nov 28, 2017
Rated: Buy
Price Target: $7
Current: $29.36
Upside: n/a
Nov 6, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.4999
Upside: n/a
Jan 30, 2015
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Jan 26, 2015
Reiterated: Buy
Price Target: $20
Current: $8.70
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $7.5 → $5
Current: $0.0001
Upside: n/a
Mar 19, 2013
Downgraded: Sell
Price Target: $0.5
Current: $0.0016
Upside: n/a